Baseline Nutritional Indices as Prognostic Indicators in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Treated with the PD-L1 Inhibitor KL-A167: A Secondary Analysis of the KL-A167 Trial. (PubMed, Cancer Manag Res) - Jun 30, 2026 - "Baseline nutritional indices, particularly PNI, were associated with OS and PFS in patients with R/M NPC treated with the PD-L1 inhibitor KL-A167. Routine baseline nutritional screening may help identify high-risk patients before immunotherapy, although the clinical benefits of early nutritional interventions remain to be confirmed."
Biomarker • IO biomarker • Journal • Nasopharyngeal Carcinoma • Oncology • Solid Tumor
|
|
Ge Song; Huilin Li; Jiacheng Li; Jitao Zhou; Junyou Ge; Kun Gao; Ruidan Li; Xingchen Peng; Yan Qing; Yiyan Pei; Youneng Wei; Yu Min; Zheran Liu; Zhigong Wei; Zijian Qin
|